Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis
2005-000129-47Phase 4Completed
- Sponsor
- UMass Chan Medical School Division of Rheumatology
- Start
- Feb 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in rheumatoid arthritis (RA), sponsored by UMass Chan Medical School Division of Rheumatology. Primary endpoints: Endothelial expression changes and Carotid intima-media thickness. Started Feb 2005; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2005-000129-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000129-47.